Neuropsychiatric products

XY-AG: Originally developed by Sanofi of France, this is the first domestically exclusive generic version of the drug, an antidepressant that represents a new breakthrough in the treatment of depression (the product has already been submitted to the SFDA for review and approval). XY-TBZ: Originally developed by Janssen, this medication treats epilepsy and migraines, and is a best-selling drug in clinical use across China, thanks to its unique mechanism of action.

Category:

Other medications

Return to list

Detailed introduction

XY-AG: Originally developed by Sanofi of France, this is the first domestically exclusive generic version of the drug, classified as an antidepressant—and represents a significant breakthrough in the treatment of depression (the product has already been submitted to the SFDA for review and approval).

XY-TBZ: Originally developed by Janssen, it treats epilepsy and migraines, is a best-selling clinical drug in China, and features a unique mechanism of action.

Keywords:

None